Welcome to our dedicated page for Helen Of Troy SEC filings (Ticker: HELE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Helen of Troy’s filings are more than routine paperwork—they unwrap how OXO kitchen tools, Hydro Flask hydration gear, and Revlon styling appliances drive revenue across the Home & Outdoor and Beauty & Wellness segments. If you have ever wondered where to spot brand acquisition costs, seasonal inventory swings, or supply-chain risks, this page delivers every disclosure the moment it hits EDGAR.
Our platform pairs each document with AI-powered summaries, turning a dense Helen of Troy annual report 10-K simplified into a three-minute read. Drill into a Helen of Troy quarterly earnings report 10-Q filing and get instant ratio analysis, or set real-time alerts for Helen of Troy Form 4 insider transactions real-time. Need to track governance? The latest Helen of Troy proxy statement executive compensation is annotated so you can see how bonuses link to segment margins. Sudden recalls or acquisitions are flagged in the Helen of Troy 8-K material events explained section, letting you gauge impact before the market reacts.
Whether you are scanning Helen of Troy insider trading Form 4 transactions, seeking Helen of Troy earnings report filing analysis, or simply understanding Helen of Troy SEC documents with AI, Stock Titan’s expert review, real-time feeds and interactive tables save hours of manual work. Investors use these insights to monitor executive stock transactions Form 4, compare brand performance quarter-over-quarter, and validate valuation models—no endless PDF scroll required.
Helen of Troy Limited reported weaker first-half fiscal 2026 results driven by softer consumer demand, tariff pressures and significant non-cash impairments. Consolidated net sales for the six months ended August 31, 2025 were $803.4 million, down 9.8% from prior year, with Organic declines largely in Beauty & Wellness and insulated beverageware categories. Management recorded substantial pre-tax asset impairment charges of approximately $326.4 million (including goodwill, indefinite-lived and definite-lived intangibles) and operating losses that reflect those write-downs. The Olive & June acquisition contributed $60.3 million to year-to-date sales; purchase consideration included initial cash of $224.7 million plus contingent consideration up to $15.0 million. Net leverage and covenant flexibility are in focus: $625 million of debt was hedged with swaps and credit facility headroom was effectively limited to $212.7 million; management expects to seek a temporary covenant amendment. Cost actions, working-capital measures and Project Pegasus initiatives were initiated to preserve liquidity.
Helen of Troy Ltd (HELE) Chief Financial Officer Brian Grass reported a sale of 322 common shares on
Krista Berry, a director of Helen Of Troy Ltd (HELE), acquired 992 restricted common shares on 09/02/2025 that vested immediately. The grant included a tax-offset right that entitles Ms. Berry to receive a cash amount to cover certain tax liabilities related to the vesting. The transaction price is reported as $0, and after the acquisition Ms. Berry beneficially owned 7,865 common shares. The Form 4 lists the filing as by one reporting person and includes Exhibit 24 (Power of Attorney) as an attachment.
Elena Otero, a director of Helen Of Troy Ltd (HELE), reported a transaction dated 09/02/2025 in which 992 restricted common shares vested immediately and were treated as an acquisition at a $0 price due to grant/vesting mechanics. Following this transaction she beneficially owns 5,083 common shares. The filing notes the vested restricted stock is accompanied by a tax-offset right that provides a cash amount to cover certain tax liabilities arising on vesting. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Tabata L. Gomez Sades, a director of Helen Of Troy Ltd (HELE), reported a change in beneficial ownership on a Form 4. On 09/02/2025 she was granted 992 common shares as restricted stock that vested immediately; the grant includes a tax-offset right to receive cash to pay related tax liabilities. The reporting shows a reported price of $0 for the award and indicates 5,083 common shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing is a routine disclosure of an insider equity award that became immediately vested.
Timothy F. Meeker, a director of Helen Of Troy Ltd (HELE), was granted 992 restricted common shares that vested immediately on 09/02/2025. The grant is accompanied by a tax-offset right that entitles the reporting person to receive a cash amount to pay certain tax liabilities arising from the vesting. After the transaction, Meeker beneficially owns 10,758 common shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025 and lists Exhibit 24 (Power of Attorney).
Helen of Troy director Thurman K. Case received a grant of 992 restricted common shares that vested immediately on 09/02/2025. The award is accompanied by a tax-offset right that entitles the reporting person to receive a cash amount to cover certain tax liabilities arising from vesting. The reported transaction shows a $0 per-share price for the grant and leaves the reporting person with 8,043 beneficially owned shares after the transaction.
Darren G. Woody, a director of Helen Of Troy Ltd (HELE), reported a transaction on 09/02/2025. He was granted 992 restricted common shares that vested immediately and carry a tax-offset right entitling him to receive cash to cover certain tax liabilities. The reported price per share is $0. Following the transaction, Mr. Woody beneficially owned 11,458 common shares. The filing also discloses indirect ownership by a spouse for a separate small holding. The Form 4 was signed by an attorney-in-fact on 09/03/2025 and lists an Exhibit 24 power of attorney.
Helen of Troy (HELE) director Vincent D. Carson reported a grant of 992 restricted common shares that vested immediately on 09/02/2025. The filing shows the shares carry a tax-offset right, which entitles the reporting person to receive a cash amount to pay certain tax liabilities upon vesting. After the transaction, Mr. Carson beneficially owns 17,162 shares. The Form 4 was filed individually and signed by an attorney-in-fact on 09/03/2025. No derivative transactions or prices were reported.